| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-08 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
| mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.25 |
1e-05 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-05 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-05 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-05 |
| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0001 |
| mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0001 |